校正型中轴型脊柱关节炎测量指数(CASMI)的建立与验证
本研究基于非axSpA人群与重度axSpA患者的脊柱活动度数据,按年龄、性别和身高重新设定BASMI各成分的正常与重度锚点,建立CASMI。在r-axSpA队列(OASIS)中,CASMI评分低于BASMI,与年龄和身高的相关性明显降低,同时结构效度与已知组区分能力得以保持。
要点
- CASMI按年龄、性别和身高校正BASMI各成分锚点,评分低于BASMI。
- CASMI与年龄、身高的相关性明显降低,非疾病因素影响减小。
- CASMI与功能、疾病活动度和结构结局的相关性与BASMI相当,已知组区分能力良好。
核心结论
- CASMI是一种按年龄、性别和身高校正的脊柱活动度评分,相比BASMI是更个体化且有效的中轴型脊柱关节炎活动度测量工具。
研究设计与样本
- 利用非axSpA个体与重度axSpA患者的脊柱活动度数据建立CASMI,并在r-axSpA人群(OASIS队列)中评估其评分范围、地板/天花板效应与结构效度。
- 每个BASMI成分的正常锚点(评分=0)取自非axSpA个体的第50百分位,重度锚点(评分=10)取自重度axSpA患者的第95百分位。
- 锚点依据非axSpA个体MOBILITY研究的回归系数,分别按年龄、性别和身高进行校正。
主要发现
- CASMI评分低于BASMI(3.2(2.0)vs 3.8(1.6)),在年龄较大和身材较矮的个体中尤为明显。
- 更多受试者被正确归入正常活动度范围,地板效应增加,天花板效应保持不变。
- CASMI与年龄和身高的相关性明显降低,与功能、疾病活动度和结构结局的相关性与BASMI相当。
- 已知组区分能力保持良好,标准化均数差始终高于0.80。
关键数值与推荐
- 正常活动度锚点为非axSpA个体第50百分位,重度活动度锚点为重度axSpA患者第95百分位,并按年龄、性别、身高校正。
- CASMI评分3.2(2.0),BASMI评分3.8(1.6)。
- 已知组区分的标准化均数差始终高于0.80。
临床怎么用
- CASMI可用于axSpA患者脊柱活动度评估,减少年龄、性别和身高对评分的干扰,尤其适用于年龄较大或身材较矮者。
- 临床应用时需注意CASMI地板效应增加,更多受试者被归入正常活动度范围。
局限性
- CASMI建立所用的非axSpA与重度axSpA数据来源及样本量在摘要中未报告。
- 结构效度评估仅在OASIS队列中进行,其他人群的适用性未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To adjust the BASMI for measurement bias related to age, sex and height, and to compare scores and construct validity of a corrected metrology index (CASMI) against BASMI. METHODS: Spinal mobility data from non-axSpA individuals and severe axSpA patients were used to develop CASMI. For each BASMI component, the anchors for normal (score=0) and severe (score=10) mobility were redefined based on the 50th percentiles of non-axSpA individuals and the 95th percentile of patients with severe axSpA respectively. These anchors were individually adjusted for age, sex, and height using the regression coefficients from the MOBILITY study of non-axSpA individuals. Score ranges, floor/ceiling and construct validity (correlations and know-group discrimination) of BASMI and CASMI were assessed in an r-axSpA-population (OASIS cohort). It was hypothesized that CASMI would reduce correlations with age/height, while maintaining construct validity. RESULTS: Applying these corrections resulted in lower CASMI scores compared with BASMI (3.2 (2.0) vs 3.8 (1.6)), particularly in older and shorter individuals. Floor effects increased as more subjects were correctly classified within the normal mobility range, while ceiling effects remained unchanged. CASMI showed markedly reduced correlations with age and height, confirming a lower influence of these non-disease factors. Construct validity was maintained, as correlations with functional, disease activity, and structural outcomes were comparable to BASMI. Known-group discrimination also remained good, with standardized mean differences consistently above 0.80. CONCLUSIONS: An age-, sex- and height-corrected mobility score, the CASMI, has been developed as a more personalised and valid measure of mobility in axSpA, compared to BASMI.
引用
- Capelusnik D, Gardiner P, Bonnen A, et al. Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI). Semin Arthritis Rheum. 2026. PMID: 42008878. doi:10.1016/j.semarthrit.2026.152981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。